Standard BioTools Inc. Other Operating Activities, Cash Flow Statement
Standard BioTools Inc. (LAB) reported Other Operating Activities, Cash Flow Statement of $46.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherOperatingActivitiesCashFlowStatement · last filed 2026-08-05
- Standard BioTools Inc. other operating activities, cash flow statement for the quarter ending 2026-06-30 was -$21.00K, a 122.83% decline year-over-year.
- Standard BioTools Inc. other operating activities, cash flow statement for the quarter ending 2026-03-31 was $67.00K, a 82.60% decline year-over-year.
- Standard BioTools Inc. other operating activities, cash flow statement for the quarter ending 2025-12-31 was -$17.00K.
- Standard BioTools Inc. other operating activities, cash flow statement for the quarter ending 2025-09-30 was $445.00K, a 83.13% increase year-over-year.
- Standard BioTools Inc. other operating activities, cash flow statement for fiscal 2025 was $905.00K, a 11.71% decline from fiscal 2024.
- Standard BioTools Inc. other operating activities, cash flow statement for fiscal 2024 was $1.02M, a 9.16% increase from fiscal 2023.
- Standard BioTools Inc. other operating activities, cash flow statement for fiscal 2023 was $939.00K, a 29.35% decline from fiscal 2022.
- Standard BioTools Inc. other operating activities, cash flow statement for fiscal 2022 was $1.33M, a 155.58% increase from fiscal 2021.
| Period end | Other Operating Activities, Cash Flow Statement 3 month | Other Operating Activities, Cash Flow Statement 3 month as first filed | Other Operating Activities, Cash Flow Statement 6 month | Other Operating Activities, Cash Flow Statement 6 month as first filed | Other Operating Activities, Cash Flow Statement 9 month | Other Operating Activities, Cash Flow Statement 9 month as first filed | Other Operating Activities, Cash Flow Statement 12 month | Other Operating Activities, Cash Flow Statement 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $46.00K 10-Q · filed 2026-08-05 | $29.00K derived: sum of 3 quarters · filed 2026-08-05 | $474.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $67.00K 10-Q · filed 2026-05-06 | $50.00K derived: sum of 2 quarters · filed 2026-05-06 | $495.00K derived: sum of 3 quarters · filed 2026-05-06 | $587.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $428.00K derived: sum of 2 quarters · filed 2026-03-16 | $520.00K derived: sum of 3 quarters · filed 2026-08-05 | $905.00K 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | $445.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $537.00K derived: sum of 2 quarters · filed 2026-08-05 | $922.00K 10-Q · filed 2025-11-04 | $836.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $477.00K 10-Q · filed 2026-08-05 | $391.00K derived: sum of 3 quarters · filed 2026-08-05 | $634.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $385.00K 10-Q · filed 2026-05-06 | $299.00K derived: sum of 2 quarters · filed 2026-05-06 | $542.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.12M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $157.00K derived: sum of 2 quarters · filed 2026-03-16 | $732.00K derived: sum of 3 quarters · filed 2026-03-16 | $1.02M 10-K · filed 2026-03-16 | ||||
| 2024-09-30 | $243.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $818.00K derived: sum of 2 quarters · filed 2025-11-04 | $1.11M 10-Q · filed 2025-11-04 | $1.44M derived: sum of 4 quarters · filed 2026-03-16 | ||||
| 2024-06-30 | $575.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15 | $868.00K 10-Q · filed 2025-08-15 | $1.20M derived: sum of 3 quarters · filed 2026-03-16 | $1.48M derived: sum of 4 quarters · filed 2026-03-16 | ||||
| 2024-03-31 | $293.00K 10-Q · filed 2025-05-06 | $621.00K derived: sum of 2 quarters · filed 2026-03-16 | $905.00K derived: sum of 3 quarters · filed 2026-03-16 | $1.18M derived: sum of 4 quarters · filed 2026-03-16 | ||||
| 2023-12-31 | $328.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $612.00K derived: sum of 2 quarters · filed 2026-03-16 | $884.00K derived: sum of 3 quarters · filed 2026-03-16 | $939.00K 10-K · filed 2026-03-16 | -$987.00K 10-K · filed 2024-03-01 | |||
| 2023-09-30 | $284.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $556.00K derived: sum of 2 quarters · filed 2024-11-06 | $611.00K 10-Q · filed 2024-11-06 | -$224.00K 10-Q · filed 2023-11-07 | $1.77M derived: sum of 4 quarters · filed 2025-03-11 | |||
| 2023-06-30 | $272.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $327.00K 10-Q · filed 2024-08-06 | -$168.00K 10-Q · filed 2023-08-08 | $1.49M derived: sum of 3 quarters · filed 2025-03-11 | $1.48M derived: sum of 4 quarters · filed 2025-03-11 | |||
| 2023-03-31 | $55.00K 10-Q · filed 2024-05-09 | -$314.00K 10-Q · filed 2023-05-09 | $1.22M derived: sum of 2 quarters · filed 2025-03-11 | $1.21M derived: sum of 3 quarters · filed 2025-03-11 | $1.28M derived: sum of 4 quarters · filed 2025-03-11 | |||
| 2022-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $1.15M derived: sum of 2 quarters · filed 2025-03-11 | $1.23M derived: sum of 3 quarters · filed 2025-03-11 | $1.33M 10-K · filed 2025-03-11 | $273.00K 10-K · filed 2023-03-14 | |||
| 2022-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $61.00K derived: sum of 2 quarters · filed 2023-11-07 | $165.00K 10-Q · filed 2023-11-07 | $288.00K derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | $72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $176.00K 10-Q · filed 2023-08-08 | $299.00K derived: sum of 3 quarters · filed 2023-08-08 | $368.00K derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | $104.00K 10-Q · filed 2023-05-09 | $227.00K derived: sum of 2 quarters · filed 2023-05-09 | $296.00K derived: sum of 3 quarters · filed 2023-05-09 | $461.00K derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $192.00K derived: sum of 2 quarters · filed 2023-03-14 | $357.00K derived: sum of 3 quarters · filed 2023-03-14 | $520.00K 10-K · filed 2023-03-14 | $2.00K 10-K · filed 2022-03-08 | |||
| 2021-09-30 | $69.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $234.00K derived: sum of 2 quarters · filed 2022-11-09 | $397.00K 10-Q · filed 2022-11-09 | $11.00K 10-Q · filed 2021-11-09 | $810.00K derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2021-06-30 | $165.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $328.00K 10-Q · filed 2022-08-09 | $63.00K 10-Q · filed 2021-08-06 | $741.00K derived: sum of 3 quarters · filed 2022-08-09 | $618.00K derived: sum of 4 quarters · filed 2022-08-09 | |||
| 2021-03-31 | $163.00K 10-Q · filed 2022-05-09 | $12.00K 10-Q · filed 2021-05-07 | $576.00K derived: sum of 2 quarters · filed 2022-05-09 | $453.00K derived: sum of 3 quarters · filed 2022-05-09 | $705.00K derived: sum of 4 quarters · filed 2022-05-09 | |||
| 2020-12-31 | $413.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $290.00K derived: sum of 2 quarters · filed 2022-03-08 | $542.00K derived: sum of 3 quarters · filed 2022-03-08 | $426.00K 10-K · filed 2022-03-08 | ||||
| 2020-09-30 | -$123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $129.00K derived: sum of 2 quarters · filed 2021-11-09 | $13.00K 10-Q · filed 2021-11-09 | $18.00K derived: sum of 4 quarters · filed 2022-03-08 | ||||
| 2020-06-30 | $252.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $136.00K 10-Q · filed 2021-08-06 | $141.00K derived: sum of 3 quarters · filed 2022-03-08 | $174.00K derived: sum of 4 quarters · filed 2022-03-08 | ||||
| 2020-03-31 | -$116.00K 10-Q · filed 2021-05-07 | $264.00K 10-Q · filed 2020-05-11 | -$111.00K derived: sum of 2 quarters · filed 2022-03-08 | -$78.00K derived: sum of 3 quarters · filed 2022-03-08 | $109.00K derived: sum of 4 quarters · filed 2022-03-08 | |||
| 2019-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $38.00K derived: sum of 2 quarters · filed 2022-03-08 | $225.00K derived: sum of 3 quarters · filed 2022-03-08 | $200.00K 10-K · filed 2022-03-08 | -$316.00K 10-K · filed 2020-02-27 | |||
| 2019-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $220.00K derived: sum of 2 quarters · filed 2020-11-09 | $195.00K 10-Q · filed 2020-11-09 | |||||
| 2019-06-30 | $187.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $162.00K 10-Q · filed 2020-08-07 | ||||||
| 2019-03-31 | -$25.00K 10-Q · filed 2020-05-11 | |||||||
| 2018-12-31 | $175.00K 10-K · filed 2021-02-25 | |||||||
| 2017-12-31 | -$890.00K 10-K · filed 2020-02-27 | -$603.00K 10-K · filed 2018-03-08 | ||||||
| 2016-12-31 | -$26.00K 10-K · filed 2019-03-18 | $252.00K 10-K · filed 2017-03-03 | ||||||
| 2015-12-31 | $137.00K 10-K · filed 2018-03-08 | |||||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |